A Phase I Study of Tagraxofusp With or Without Chemotherapy in Pediatric Patients with Relapsed or Refractory CD123 Expressing Hematologic Malignancies
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/cancer.jpg)
Details
Age
Child to Adult
Locations
Childrens Hospital Colorado
Principal Investigator
![Photograph of Kelly Faulk](https://som.ucdenver.edu/FIMS/Content/faculty/14055/CU-Doctors-14055.jpg)
Kelly Faulk
Study ID
Protocol Number: 22-2360
More information available at ClinicalTrials.gov: NCT05476770
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers